Bio-Techne (TECH) –
-
BIO-TECHNE TO PRESENT AT THE BofA SECURITIES HEALTH CARE CONFERENCE 2024
-
BIO-TECHNE TO PRESENT AT THE 27TH ANNUAL MEETING OF THE AMERICAN SOCIETY OF GENE & CELL THERAPY (ASGCT)
-
Form 10-Q BIO-TECHNE Corp For: Mar 31
-
Form 4 BIO-TECHNE Corp For: May 01 Filed by: Klimovsky Judith V
-
Form 3 BIO-TECHNE Corp For: Apr 24 Filed by: Klimovsky Judith V
-
Bio-Techne Corp. (TECH) PT Raised to $83 at Scotiabank
-
Bio-Techne Corp. (TECH) PT Raised to $81 at Baird
-
Bio-Techne Corp. (TECH) PT Raised to $72 at RBC Capital
-
Bio-Techne (TECH) Tops Q3 EPS by 3c
-
Bio-Techne (TECH) Declares $0.08 Quarterly Dividend; 0.5% Yield
-
BIO-TECHNE DECLARES DIVIDEND
-
BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
-
Form 8-K BIO-TECHNE Corp For: May 01
-
Form 8-K BIO-TECHNE Corp For: Apr 24
-
BIO-TECHNE APPOINTS DR. JUDITH KLIMOVSKY TO BOARD OF DIRECTORS
-
Bio-Techne (TECH) Announces New Distribution Agreement With Thermo Fisher Scientific (TMO)
-
BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH THERMO FISHER SCIENTIFIC
-
BIO-TECHNE AND NOVOMOL-Dx ANNOUNCE POINT-OF-CARE OCULAR BIOMARKER ASSAY
-
BIO-TECHNE FILES PATENT INFRINGEMENT LAWSUIT AGAINST MOLECULAR INSTRUMENTS
-
Bio-Techne Corp. (TECH) PT Lowered to $82 at Deutsche Bank
-
BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 1, 2024, TO ANNOUNCE THIRD QUARTER FISCAL 2024 FINANCIAL RESULTS
-
BIO-TECHNE SURPASSES 10,000 PEER-REVIEWED PUBLICATIONS CITING RNAscope TECHNOLOGY
-
Form 4 BIO-TECHNE Corp For: Apr 03 Filed by: Bohnen Shane
-
BIO-TECHNE TO PRESENT AT THE 2024 AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR) CONFERENCE
-
BIO-TECHNE RECEIVES CiteAb'S ELISA KIT SUPPLIER OF THE YEAR AND SPATIAL BIOLOGY INNOVATION AWARDS
-
BIO-TECHNE AND NIKON INSTRUMENTS INC. ANNOUNCE PARTNERSHIP TO EXPAND ACCESS TO INNOVATIVE SPATIAL BIOLOGY SERVICES
-
Bio-Techne (TECH) Receives EU Class C Certification for QuantideX
-
BIO-TECHNE RECEIVES EUROPEAN IVDR CERTIFICATION FOR DIAGNOSTIC TEST TO MONITOR CHRONIC MYELOID LEUKEMIA
-
BIO-TECHNE TO PRESENT AT THE KEYBANC LIFE SCIENCES & MEDTECH INVESTOR FORUM
-
Form 4 BIO-TECHNE Corp For: Mar 07 Filed by: Nusse Roeland
-
Form 144 BIO-TECHNE Corp Filed by: Nusse Roeland
-
BIO-TECHNE TO PRESENT AT THE BARCLAYS 26th ANNUAL GLOBAL HEALTHCARE CONFERENCE
-
Form SC 13G/A BIO-TECHNE Corp Filed by: VANGUARD GROUP INC
-
Form 10-Q BIO-TECHNE Corp For: Dec 31
-
Scotiabank Starts Bio-Techne Corp. (TECH) at Sector Outperform
-
Form 4 BIO-TECHNE Corp For: Feb 01 Filed by: Geist William
-
Form 4 BIO-TECHNE Corp For: Feb 01 Filed by: McManus Matthew
-
Form 4 BIO-TECHNE Corp For: Nov 01 Filed by: Kelderman Kim
-
Form 3 BIO-TECHNE Corp For: Jan 08 Filed by: McManus Matthew
-
Bio-Techne Corp. (TECH) PT Lowered to $80 at Craig-Hallum
-
Bio-Techne Corp. (TECH) PT Lowered to $87 at Stephens
-
Bio-Techne Corp. (TECH) PT Raised to $73 at Baird
-
Bio-Techne Corp. (TECH) PT Lowered to $85 at Deutsche Bank
-
Stifel Downgrades Bio-Techne Corp. (TECH) to Hold
-
Bio-Techne Corp. (TECH) PT Lowered to $75 at RBC Capital
-
Bio-Techne (TECH) Misses Q2 EPS by 1c
-
Bio-Techne (TECH) Declares $0.08 Quarterly Dividend; 0.5% Yield
-
BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
-
Form 8-K BIO-TECHNE Corp For: Feb 01
-
BIO-TECHNE DECLARES DIVIDEND
Back to TECH Stock Lookup
